Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04769466 · ClinicalTrials.gov registry record · NA
LifeBio Memory Digital Reminiscence Platform
A NA study of Dementia and Cognitive Impairment, sponsored by Benjamin Rose Institute on Aging.
- Completed
- Registry status
- NA
- Development phase
- 234
- Enrollment target
- 1
- Study location
NCT04769466: Completed NA study of Dementia and Cognitive Impairment, sponsored by Benjamin Rose Institute on Aging.
NCT04769466 is a NA study of Dementia and Cognitive Impairment that has completed, run by Benjamin Rose Institute on Aging. The registered enrollment target is 234 participants, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04769466, a NA study of Dementia and Cognitive Impairment, has completed, sponsored by Benjamin Rose Institute on Aging.
- COMPLETED
- Registry status
- NA
- Development phase
- 234 participants
- Enrollment target
- 1
- Study location
Study Summary
Non-pharmacological interventions and person-centered care strategies are important elements of care for people with Alzheimer's disease and related dementias. Life story work, which uses written and oral life histories to elicit conversation and memories, is an effective intervention for individuals with dementia; however, because of the time-consuming nature of generating useful life story materials, has not been widely implemented in nursing homes and other care environments. LifeBio Inc. will develop an easy-to-use reminiscence therapy platform - LifeBio MemoryTM - with a novel machine-learning-based application that converts speech to text and generates life stories to serve as an interactive tool to cultivate communication between people living with dementia and their family and caregivers.
Primary Outcome
10-item Measure of depressive symptomatology; Scale: 0 (rarely or none of the time) to 3 (most or almost all of the time); Possible scores range from 0 (minimum) to 30 (maximum). Higher scores indicate higher frequency of reported depressive symptomology.
Conditions Studied
Interventions
- OTHER LifeBio Memory
Study Locations (1)
Ohio
- Benjamin Rose Institute on Aging - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 234 participants |
| Start Date | 2022-03-22 |
| Est. Completion | 2024-04-30 |
| Phase | NA |
What the finished NCT04769466 record still lists
NCT04769466 is an interventional study that assigns participants to a tested intervention. The registered 234 participants enrollment target is mid-sized for trials with a published cap, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Dementia appearing as the primary indexed condition, and to 1 intervention - of which LifeBio Memory is the first listed.
NCT04769466 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04769466 about?
NCT04769466 is a clinical study titled "LifeBio Memory Digital Reminiscence Platform". Non-pharmacological interventions and person-centered care strategies are important elements of care for people with Alzheimer's disease and related dementias. Life story work, which uses written and oral life histories to elicit conversation and memories, is an effective intervention for individual...
What is the current status of trial NCT04769466?
This trial is currently completed. It is a NA study. The enrollment target is 234 participants. The study started on 2022-03-22. Estimated completion is 2024-04-30.
What conditions does trial NCT04769466 study?
This clinical trial studies the following conditions: Dementia, Cognitive Impairment.
What interventions are being tested in trial NCT04769466?
The interventions under investigation include: LifeBio Memory (OTHER).
Who is sponsoring clinical trial NCT04769466?
This trial is sponsored by Benjamin Rose Institute on Aging, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04769466 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dementia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04769466's enrollment target sits among peer trials
234 83rd of 199 higher than 117 of 199 other Dementia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dementia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
δ in Dementia Clinical Trials
RECRUITING · NA
-
Caregiver as Navigator: Develop Skills Online (CAN-DO)
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Caregiver Bootcamp
RECRUITING · NA
-
Enhancing Triadic Communication About Cognition for Older Adults With Alzheimer's Disease or Related Dementias Facing a Cancer Management Decision
RECRUITING · NA
-
Effect of Cognitive Empathy Training on Dementia Caregivers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04942717 · 234 participants · NA
Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values
- NCT05208671 · 234 participants · NA
Nutrition to Optimize, Understand, and Restore Insulin Sensitivity in HIV for Oklahoma
- NCT05444465 · 234 participants · NA
Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears
- NCT05720338 · 234 participants · Phase 3
Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI